» Articles » PMID: 38758542

Deactivation of the Unfolded Protein Response Aggravated Renal AA Amyloidosis in HSF1 Deficiency Mice

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2024 May 17
PMID 38758542
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic amyloid A (AA) amyloidosis, which is considered the second most common form of systemic amyloidosis usually takes place several years prior to the occurrence of chronic inflammation, generally involving the kidney. Activated HSF1, which alleviated unfolded protein response (UPR) or enhanced HSR, is the potential therapeutic target of many diseases. However, the effect of HSF1 on AA amyloidosis remains unclear. This study focused on evaluating effect of HSF1 on AA amyloidosis based on HSF1 knockout mice. As a result, aggravated amyloid deposits and renal dysfunction have been found in HSF1 knockout mice. In progressive AA amyloidosis, HSF1 deficiency enhances serum amyloid A production might to lead to severe AA amyloid deposition in mice, which may be related to deactivated unfolded protein response as well as enhanced inflammation. Thus, HSF1 plays a significant role on UPR related pathway impacting AA amyloid deposition, which can mitigate amyloidogenic proteins from aggregation pathologically and is the possible way for intervening with the pathology of systemic amyloid disorder. In conclusion, HSF1 could not only serve as a new target for AA amyloidosis treatment in the future, but HSF1 knockout mice also can be considered as a valuable novel animal model for renal AA amyloidosis.

References
1.
Inouye S, Fujimoto M, Nakamura T, Takaki E, Hayashida N, Hai T . Heat shock transcription factor 1 opens chromatin structure of interleukin-6 promoter to facilitate binding of an activator or a repressor. J Biol Chem. 2007; 282(45):33210-7. DOI: 10.1074/jbc.M704471200. View

2.
Kendi Celebi Z, Kiremitci S, Ozturk B, Akturk S, Erdogmus S, Duman N . Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis. Amyloid. 2017; 24(3):176-182. DOI: 10.1080/13506129.2017.1350158. View

3.
Kampinga H, Bergink S . Heat shock proteins as potential targets for protective strategies in neurodegeneration. Lancet Neurol. 2016; 15(7):748-759. DOI: 10.1016/S1474-4422(16)00099-5. View

4.
Ni M, Lee A . ER chaperones in mammalian development and human diseases. FEBS Lett. 2007; 581(19):3641-51. PMC: 2040386. DOI: 10.1016/j.febslet.2007.04.045. View

5.
Hoozemans J, van Haastert E, Nijholt D, Rozemuller A, Scheper W . Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease. Neurodegener Dis. 2012; 10(1-4):212-5. DOI: 10.1159/000334536. View